AEON Biopharma, Inc.
AMEXAEON short interest bounced 29.5% over the past week to 182,970 shares, though it fell 17.2% on May 18 alone. Stock remains cheap on fundamentals with high borrow availability at 1,049% despite modest 32% utilization.
Short interest % of float, cost to borrow, utilization, and put/call ratio for AEON are part of the ORTEX premium tier. Sign up to read the live numbers alongside the analysis.
Snapshot as of 20 May 2026
AEON Biopharma enters its May 21 earnings report under significant pressure, having already delivered a miss just days ago — and the market has not been forgiving. The stock dropped 12% on May 14 after Q1 EPS came in…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for AEON — free to start on ORTEX.
Sign up for free →Open AEON on ORTEXPulses are triggered by ORTEX's live data feeds. The full signal history, thresholds, and alerts are on ORTEX.
Live AEON data →